{"id":"W4413230133","doi":"10.3389/fonc.2025.1544967","title":"Safety of unconventional antibody-drug conjugate L-DOS47 in a phase I/II monotherapy study targeting advanced NSCLC","year":2025,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Calgary Laboratory Services; Helix Biopharma (Canada); University of Calgary","funders":"","keywords":"Tolerability; Medicine; Carcinoembryonic antigen; Adverse effect; Regimen; Internal medicine; Lung cancer; Phases of clinical research; Cancer; Antibody-drug conjugate; Oncology; Gastroenterology; Antibody; Toxicity; Pharmacology; Immunology; Monoclonal antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006469862,0.0007117487,0.001499374,0.0002947817,0.0002158372,0.0008331072,0.0005182733,0.0008018097,0.002184921],"category_scores_gemma":[0.0003699385,0.0003161598,0.000844222,0.0002681035,0.0005832329,0.0004641544,0.0001818646,0.001365016,0.000489657],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005489536,"about_ca_system_score_gemma":0.001008109,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004228673,"about_ca_topic_score_gemma":0.0014574,"domain_scores_codex":[0.9997976,0.0000937206,0.00001175528,0.00003816208,0.00002070535,0.00003800721],"domain_scores_gemma":[0.9996915,0.00004644662,0.00007712281,0.00003159155,0.00002476742,0.0001285847],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4827366,0.0510216,0.008660673,0.002252026,0.002075637,0.0005893061,0.0005195462,0.006072848,0.2733621,0.0007582743,0.003996482,0.1679548],"study_design_scores_gemma":[0.2463354,0.7110589,0.0119238,0.0001000003,0.0007845721,0.0004504838,0.0001224449,0.001999661,0.02132799,0.0003302115,0.005519988,0.00004659307],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950145,0.001932966,0.0004578375,0.0001952961,0.00007150325,0.0008530729,0.0004201802,0.00006311819,0.0009915429],"genre_scores_gemma":[0.9931309,0.001916148,0.000672968,0.0003505781,0.00006119709,0.0008756628,0.0007611007,0.00001922542,0.002212243],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002184921,"threshold_uncertainty_score":0.007309318,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01386658874962423,"score_gpt":0.397799303620999,"score_spread":0.3839327148713748,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}